ITI wins "Life Science Company of the Year"
Immunomic Therapeutics, Inc. is the proud recipient of Tech Council of MD's "Life Science Company of the Year". Celebrated at the Industry Awards, it is the only awards ceremony that honors the best in Maryland’s life science and technology community. This celebration is one of Maryland’s largest and most prestigious award ceremonies and recognizes executives, businesses, and innovative technology developed in Maryland and the surrounding regions.
Dr. Duane Mitchell, currently leading research studies at the University of Florida with his mRNA transfected DC vaccine that codes for pp65 and LAMP for people that suffer from Glioblastoma, received Top 10 Clinical Research Achievement Awards recognition for their ATTAC clinical trial.
ITI is looking forward to the ATTAC II trial results, which include testing full-length LAMP!
Oct 2-4, 2016 | Boston, MAISV Summit
Nov 9-13 | National Harbor, DCSITC
Nov 11-13 | Middleburg, VAINOVA Summit
Dec 1-2, 2016 | New York, NYLife Sciences Summit
Dec 7-9, 2016 | Boston, MAImmunization and Vaccine Summit
We Work For Health
"We Work for Health" partnering with ITI
We Work For Health is a grassroots initiative that shows how biopharmaceutical research and medical innovation work together to create a strong, vibrant economy and a healthier America. We unite biopharmaceutical companies with business and community partners to raise awareness about the vital role we all play in delivering life-saving and life-enhancing advancements in medicine, while educating elected leaders on the impact that public policies have on our ability to continue to innovate.